Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: 17:01:13
293,90 DKK
Kurs
Kurs
0,51%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
409,95 DKK
52 Wochen Hoch
52 Wochen Hoch
- Neutral
- Seit dem 07.07.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 0 Monate | 0 Monate | 293,90 265 | 293,90 | 265 | 9,833277 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12 Monate | 12 Monate | 293,90 290 | 293,90 | 290 | 1,326982 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 24.08.2026 0 Monate | 24.08.2026 | 0 Monate | 293,90 275 | 293,90 | 275 | 6,430759 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 293,90 290 | 293,90 | 290 | 1,326982 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.08.2026 0 Monate | 11.08.2026 | 0 Monate | 293,90 305 | 293,90 | 305 | 3,776795 | BERENBERG | ||
| Novo Nordisk AS | 07.08.2026 0 Monate | 07.08.2026 | 0 Monate | 293,90 | 293,90 | -- | DZ BANK | |||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 293,90 285 | 293,90 | 285 | 3,028241 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 293,90 290 | 293,90 | 290 | 1,326982 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 293,90 200 | 293,90 | 200 | 31,949643 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 293,90 332 | 293,90 | 332 | 12,963593 | UBS | ||
| Novo Nordisk AS | 05.08.2026 12 Monate | 05.08.2026 | 12 Monate | 293,90 310 | 293,90 | 310 | 5,478054 | BARCLAYS | ||
| Novo Nordisk AS | 04.08.2026 12 Monate | 04.08.2026 | 12 Monate | 293,90 285 | 293,90 | 285 | 3,028241 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 04.08.2026 0 Monate | 04.08.2026 | 0 Monate | 293,90 332 | 293,90 | 332 | 12,963593 | UBS | ||
| Novo Nordisk AS | 31.07.2026 0 Monate | 31.07.2026 | 0 Monate | 293,90 250 | 293,90 | 250 | 14,937053 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 293,90 290 | 293,90 | 290 | 1,326982 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.07.2026 0 Monate | 10.07.2026 | 0 Monate | 293,90 332 | 293,90 | 332 | 12,963593 | UBS | ||
| Novo Nordisk AS | 29.06.2026 12 Monate | 29.06.2026 | 12 Monate | 293,90 285 | 293,90 | 285 | 3,028241 | JEFFERIES | ||
| Novo Nordisk AS | 28.06.2026 0 Monate | 28.06.2026 | 0 Monate | 293,90 250 | 293,90 | 250 | 14,937053 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 293,90 290 | 293,90 | 290 | 1,326982 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.06.2026 0 Monate | 16.06.2026 | 0 Monate | 293,90 325 | 293,90 | 325 | 10,581831 | BERENBERG | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 293,90 290 | 293,90 | 290 | 1,326982 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 293,90 250 | 293,90 | 250 | 14,937053 | JPMORGAN | ||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 293,90 250 | 293,90 | 250 | 14,937053 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 293,90 305 | 293,90 | 305 | 3,776795 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 293,90 270 | 293,90 | 270 | 8,132018 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 293,90 290 | 293,90 | 290 | 1,326982 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 293,90 290 | 293,90 | 290 | 1,326982 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 293,90 300 | 293,90 | 300 | 2,075536 | BARCLAYS | ||
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 293,90 270 | 293,90 | 270 | 8,132018 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 293,90 175 | 293,90 | 175 | 40,455937 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 293,90 290 | 293,90 | 290 | 1,326982 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 293,90 290 | 293,90 | 290 | 1,326982 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 293,90 | 293,90 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 293,90 300 | 293,90 | 300 | 2,075536 | BARCLAYS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 293,90 332 | 293,90 | 332 | 12,963593 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 293,90 250 | 293,90 | 250 | 14,937053 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 293,90 263 | 293,90 | 263 | 10,51378 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 293,90 250 | 293,90 | 250 | 14,937053 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 293,90 175 | 293,90 | 175 | 40,455937 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 293,90 300 | 293,90 | 300 | 2,075536 | BARCLAYS | ||
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 293,90 250 | 293,90 | 250 | 14,937053 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 293,90 275 | 293,90 | 275 | 6,430759 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 293,90 270 | 293,90 | 270 | 8,132018 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 293,90 250 | 293,90 | 250 | 14,937053 | JPMORGAN | ||
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 293,90 270 | 293,90 | 270 | 8,132018 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 293,90 332 | 293,90 | 332 | 12,963593 | UBS | ||
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 293,90 270 | 293,90 | 270 | 8,132018 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 293,90 263 | 293,90 | 263 | 10,51378 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 293,90 270 | 293,90 | 270 | 8,132018 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 293,90 250 | 293,90 | 250 | 14,937053 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 293,90 275 | 293,90 | 275 | 6,430759 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 293,90 270 | 293,90 | 270 | 8,132018 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 293,90 250 | 293,90 | 250 | 14,937053 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 293,90 270 | 293,90 | 270 | 8,132018 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 293,90 270 | 293,90 | 270 | 8,132018 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 293,90 300 | 293,90 | 300 | 2,075536 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 293,90 250 | 293,90 | 250 | 14,937053 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 293,90 270 | 293,90 | 270 | 8,132018 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 293,90 260 | 293,90 | 260 | 11,534536 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 293,90 270 | 293,90 | 270 | 8,132018 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 293,90 270 | 293,90 | 270 | 8,132018 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 293,90 400 | 293,90 | 400 | 36,100715 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 293,90 250 | 293,90 | 250 | 14,937053 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 293,90 400 | 293,90 | 400 | 36,100715 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 293,90 332 | 293,90 | 332 | 12,963593 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 293,90 340 | 293,90 | 340 | 15,685607 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 293,90 275 | 293,90 | 275 | 6,430759 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 293,90 350 | 293,90 | 350 | 19,088125 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 293,90 340 | 293,90 | 340 | 15,685607 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 293,90 275 | 293,90 | 275 | 6,430759 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 293,90 250 | 293,90 | 250 | 14,937053 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 293,90 270 | 293,90 | 270 | 8,132018 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 293,90 340 | 293,90 | 340 | 15,685607 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 293,90 340 | 293,90 | 340 | 15,685607 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 293,90 340 | 293,90 | 340 | 15,685607 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 293,90 340 | 293,90 | 340 | 15,685607 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 293,90 400 | 293,90 | 400 | 36,100715 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 293,90 275 | 293,90 | 275 | 6,430759 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 293,90 360 | 293,90 | 360 | 22,490643 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 293,90 360 | 293,90 | 360 | 22,490643 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 293,90 360 | 293,90 | 360 | 22,490643 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 293,90 350 | 293,90 | 350 | 19,088125 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 293,90 332 | 293,90 | 332 | 12,963593 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 293,90 475 | 293,90 | 475 | 61,619599 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 293,90 332 | 293,90 | 332 | 12,963593 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 293,90 350 | 293,90 | 350 | 19,088125 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 293,90 270 | 293,90 | 270 | 8,132018 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 293,90 350 | 293,90 | 350 | 19,088125 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 293,90 350 | 293,90 | 350 | 19,088125 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 293,90 360 | 293,90 | 360 | 22,490643 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 293,90 390 | 293,90 | 390 | 32,698197 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 293,90 350 | 293,90 | 350 | 19,088125 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 293,90 270 | 293,90 | 270 | 8,132018 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 293,90 436 | 293,90 | 436 | 48,349779 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 293,90 415 | 293,90 | 415 | 41,204491 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 293,90 360 | 293,90 | 360 | 22,490643 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 293,90 270 | 293,90 | 270 | 8,132018 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 293,90 390 | 293,90 | 390 | 32,698197 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 293,90 390 | 293,90 | 390 | 32,698197 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 293,90 360 | 293,90 | 360 | 22,490643 | BARCLAYS |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 04.11.2026 | Bericht zum 3. Quartal Novo Nordisk A/S: Third quarter 2026 | Novo Nordisk A/S: Third quarter 2026 |
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M